Rosenberg Dori, Kadokura Elyse A, Bouldin Erin D, Miyawaki Christina E, Higano Celestia S, Hartzler Andrea L
Group Health Research Institute, Seattle, WA.
University of Washington, Seattle, WA.
AMIA Annu Symp Proc. 2017 Feb 10;2016:1050-1059. eCollection 2016.
Prior research has not examined the acceptability of commercially available fitness tracking devices in men with prostate cancer, many of whom are at risk for conditions that physical activity could alleviate. We conducted an exploratory 3-week field study to examine acceptability of the Fitbit Zip and attitudes towards integrating fitness tracking into clinical care among men with prostate cancer. Twenty-six men used the Fitbit Zip for a one-week baseline phase followed by a 2-week optional use phase and then completed in-depth interviews. Interview data was analyzed using inductive thematic analysis. Participants found the device comfortable and easy to wear. Barriers to use included health and technology difficulties. Participants expressed value in sharing Fitbit data with their health care team. Findings support the use of easy to use and simple fitness trackers among men with prostate cancer and there could be opportunities to integrate fitness tracker data into clinical care.
先前的研究尚未考察市面上可买到的健身追踪设备在前列腺癌男性患者中的可接受性,其中许多人面临身体活动可缓解的疾病风险。我们开展了一项为期3周的探索性实地研究,以考察Fitbit Zip在前列腺癌男性患者中的可接受性以及他们对将健身追踪纳入临床护理的态度。26名男性在为期1周的基线阶段使用了Fitbit Zip,随后进入为期2周的可选使用阶段,然后完成深度访谈。访谈数据采用归纳主题分析法进行分析。参与者发现该设备佩戴舒适且易于穿戴。使用的障碍包括健康和技术方面的困难。参与者表示与医疗团队共享Fitbit数据很有价值。研究结果支持在前列腺癌男性患者中使用易于使用且简单的健身追踪器,并且有可能将健身追踪器数据纳入临床护理。